Your browser is no longer supported. Please, upgrade your browser.
LJPC La Jolla Pharmaceutical Company daily Stock Chart
La Jolla Pharmaceutical Company
Index- P/E- EPS (ttm)-2.89 Insider Own0.50% Shs Outstand27.33M Perf Week-16.67%
Market Cap93.26M Forward P/E- EPS next Y-1.33 Insider Trans- Shs Float26.96M Perf Month-19.24%
Income-78.60M PEG- EPS next Q-0.54 Inst Own89.20% Short Float12.61% Perf Quarter-16.26%
Sales26.40M P/S3.53 EPS this Y45.20% Inst Trans2.02% Short Ratio8.20 Perf Half Y-55.96%
Book/sh-2.90 P/B- EPS next Y28.50% ROA-62.00% Target Price- Perf Year-51.53%
Cash/sh2.61 P/C1.30 EPS next 5Y13.20% ROE129.00% 52W Range2.30 - 9.38 Perf YTD-13.49%
Dividend- P/FCF- EPS past 5Y-16.60% ROI183.30% 52W High-63.75% Beta2.73
Dividend %- Quick Ratio4.30 Sales past 5Y- Gross Margin89.10% 52W Low47.83% ATR0.24
Employees90 Current Ratio4.40 Sales Q/Q1.80% Oper. Margin- RSI (14)33.09 Volatility6.59% 5.97%
OptionableYes Debt/Eq- EPS Q/Q49.10% Profit Margin- Rel Volume0.65 Prev Close3.59
ShortableYes LT Debt/Eq- EarningsAug 06 BMO Payout- Avg Volume414.80K Price3.40
Recom2.30 SMA20-16.00% SMA50-17.01% SMA200-36.50% Volume269,112 Change-5.29%
Nov-26-19Downgrade H.C. Wainwright Buy → Neutral
Nov-25-19Downgrade SunTrust Buy → Hold
Jan-23-19Upgrade JP Morgan Underweight → Neutral
Jan-14-19Upgrade Jefferies Underperform → Hold
Feb-12-18Downgrade Jefferies Buy → Underperform
Jan-25-18Reiterated Chardan Capital Markets Neutral $90 → $100
Dec-26-17Reiterated SunTrust Buy $57 → $65
Dec-22-17Reiterated SunTrust Buy $67 → $65
Dec-22-17Reiterated H.C. Wainwright Buy $62 → $91
Dec-21-17Initiated H.C. Wainwright Buy $62
Dec-08-17Downgrade JP Morgan Overweight → Underweight
Aug-30-17Initiated JP Morgan Overweight $36
Feb-27-17Reiterated SunTrust Buy $38 → $57
Jun-22-16Initiated SunTrust Buy $30
May-24-16Initiated Lake Street Buy $25
Sep-08-15Reiterated Chardan Capital Markets Buy $60 → $80
Jul-07-15Reiterated Chardan Capital Markets Buy $54 → $60
May-11-15Reiterated H.C. Wainwright Buy $29 → $20
Apr-21-15Initiated Oppenheimer Outperform $43
Mar-20-15Reiterated H.C. Wainwright Buy $20 → $29
Oct-19-20 03:30PM  
Oct-09-20 10:49AM  
Aug-25-20 08:31AM  
Aug-21-20 02:02PM  
Aug-06-20 08:30AM  
Jul-28-20 04:16PM  
Jun-24-20 07:30AM  
Jun-22-20 12:14PM  
Jun-14-20 07:00AM  
Jun-10-20 04:22PM  
May-21-20 08:30AM  
May-07-20 12:55PM  
May-06-20 08:41AM  
May-04-20 09:55AM  
Apr-27-20 12:31PM  
Apr-13-20 08:30AM  
Apr-07-20 08:30AM  
Apr-06-20 08:30AM  
Apr-03-20 08:30AM  
Apr-02-20 08:30AM  
Mar-13-20 08:00AM  
Mar-02-20 09:55AM  
Feb-24-20 12:30PM  
Jan-27-20 08:23AM  
Jan-18-20 05:09PM  
Jan-15-20 07:00AM  
Jan-09-20 08:00AM  
Dec-13-19 03:07PM  
Nov-26-19 08:06AM  
Nov-25-19 09:04AM  
Nov-15-19 09:52AM  
Nov-12-19 06:35PM  
Nov-11-19 09:59AM  
Oct-16-19 10:32AM  
Aug-29-19 09:00AM  
Aug-16-19 02:38PM  
Aug-14-19 03:36PM  
Aug-01-19 09:35AM  
Jul-30-19 11:53AM  
Jul-23-19 09:00AM  
Jul-01-19 08:39AM  
Jun-28-19 06:30AM  
Jun-11-19 11:55AM  
Jun-07-19 02:02PM  
Jun-06-19 09:00AM  
May-22-19 01:49PM  
May-06-19 06:25PM  
May-02-19 10:33AM  
Apr-29-19 01:25PM  
Apr-24-19 09:00AM  
Mar-11-19 07:30AM  
Mar-08-19 02:49PM  
Mar-07-19 04:01PM  
Mar-06-19 08:56AM  
Mar-05-19 07:24AM  
Mar-04-19 06:33PM  
Feb-25-19 04:04PM  
Feb-14-19 07:18PM  
Feb-05-19 08:20AM  
Jan-18-19 07:00AM  
Jan-10-19 07:00AM  
Jan-09-19 11:28AM  
Jan-07-19 10:25PM  
Jan-04-19 09:00AM  
Dec-22-18 01:38AM  
Nov-06-18 08:35AM  
Oct-31-18 12:04PM  
Oct-25-18 03:55PM  
Oct-24-18 06:10PM  
Oct-18-18 04:01PM  
Oct-16-18 11:21AM  
Aug-16-18 08:00AM  
Aug-13-18 03:35PM  
Aug-09-18 12:51PM  
Aug-08-18 08:00PM  
Aug-03-18 09:00AM  
Aug-01-18 05:39PM  
La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TANG KEVIN CDirectorSep 09Buy4.03126,665509,9409,405,490Sep 09 06:55 PM
RAMSAY DAVID ADirectorSep 08Buy3.831,0003,83048,000Sep 10 04:02 PM
TANG KEVIN CDirectorSep 08Buy3.9084,152328,5299,278,825Sep 09 06:55 PM
TANG KEVIN CDirectorSep 04Buy3.8267,552258,3599,194,673Sep 09 06:55 PM
RAMSAY DAVID ADirectorAug 24Buy3.767,00026,28947,000Aug 24 04:22 PM
RAMSAY DAVID ADirectorAug 21Buy3.9728,000111,10840,000Aug 24 04:22 PM
RAMSAY DAVID ADirectorAug 20Buy4.1712,00050,06012,000Aug 24 04:22 PM
TANG KEVIN CDirectorAug 14Buy3.88168,669653,6949,127,121Aug 14 04:49 PM
TANG KEVIN CDirectorAug 13Buy3.65219,465800,5868,958,452Aug 14 04:49 PM
TANG KEVIN CDirectorAug 12Buy3.4743,513150,8208,738,987Aug 14 04:49 PM
TANG KEVIN CDirectorJun 04Buy4.94215,8121,065,6368,695,474Jun 04 06:26 PM
TANG KEVIN CDirectorJun 03Buy4.90145,764714,7838,479,662Jun 04 06:26 PM
TANG KEVIN CDirectorJun 02Buy4.88253,5531,237,0608,333,898Jun 04 06:26 PM
TANG KEVIN CDirectorFeb 03Buy6.8075,003509,8338,080,345Feb 03 05:02 PM
TANG KEVIN CDirectorJan 31Buy6.7513,29289,7058,005,342Feb 03 05:02 PM
TANG KEVIN CDirectorJan 30Buy6.7281,475547,4317,992,050Feb 03 05:02 PM
Wellinghoff DarrylChief Commercial OfficerJan 14Buy8.233,00024,6776,545Jan 16 04:05 PM
TANG KEVIN CDirectorJan 13Buy6.661,253,8788,351,5807,910,575Jan 13 05:59 PM
TANG KEVIN CDirectorJan 10Buy5.70717,8044,090,9096,656,697Jan 13 05:59 PM
TANG KEVIN CDirectorJan 09Buy4.991,000,0004,991,9805,938,893Jan 13 05:59 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.